Legend Biotech Corp. (LEGN) PT Raised to $64; RBC Capital: 'We see opportunity for share appreciation'
Tweet Send to a Friend
(Updated - May 13, 2026 8:50 AM EDT)
RBC Capital analyst Leonid Timashev raised the price target on Legend ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
RBC Capital analyst Leonid Timashev raised the price target on Legend ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
